Inventor · Dunedin, NZ

Lesley Larsen

12Patents
3h-index
33Co-inventors
56Inventor score

Filing activity: May 30, 2003 → Dec 3, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US7763747B2 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease Chemistry; Metallurgy 15 Active
US7514583B2 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease Chemistry; Metallurgy 10 Expired
US7601876B2 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis Chemistry; Metallurgy 4 Active
US8586585B2 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease Chemistry; Metallurgy 1 Active
US10494344B2 Carbon monoxide releasing norbornenone compounds Chemistry; Metallurgy 1 Active
US8163957B2 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease Chemistry; Metallurgy 1 Active
US9051253B2 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's Chemistry; Metallurgy 0 Active
US8592476B2 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies Chemistry; Metallurgy 0 Active
US11072584B2 Carbon monoxide releasing norbornenone compounds Chemistry; Metallurgy 0 Active
US8829198B2 Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies Chemistry; Metallurgy 0 Active
US9133176B2 Isolation, purification and synthesis of procyanidin B2 and uses thereof Chemistry; Metallurgy 0 Active
US7807668B2 Anti-inflammatory compounds Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.